Latest News & Features
Big Pharma
The sale of counterfeit drugs is the target of new legislation proposed by the Russian government, according to news agency Tass. 12 November 2014
Americas
Healthcare company PDL BioPharma has announced that it will soon gain royalties from sales of Sanofi’s Cerdelga (eliglustat) drug, used to treat Gaucher disease. 11 November 2014
Asia
The European Patent Office has agreed a new deal with the Intellectual Property Office of India designed to support innovation in both regions. 10 November 2014
Americas
Glenmark Generics has been granted approval to market a generic version of AstraZeneca’s ulcer treatment drug Prilosec (omeprazole delayed release capsules). 7 November 2014
Biotechnology
Law firm Eversheds has expanded its IP practice in Belgium with the addition of a new life sciences partner. 6 November 2014
Americas
Healthcare company Theranos has sued medical equipment supplier Becton, Dickinson, seeking a judgment of non-infringement over a disputed trademark. 6 November 2014
Americas
A Canadian children’s hospital has launched a lawsuit focusing on whether genes should be patentable; the first of its kind in the country. 6 November 2014
Big Pharma
Depositing a microorganism in a country may be crucial for obtaining a method patent in that jurisdiction, but can come with its pitfalls, says Peter ten Haaft. 4 November 2014
Americas
Protecting rights related to desirable plant species is a delicate process, says Gabriel Di Blasi. 4 November 2014
Biotechnology
Earlier this year, the Advocate General of
the CJEU opined that stem cells from parthenotes are patentable. Franz-Josef Zimmer and Markus Grammel examine the reasoning behind his opinion. 4 November 2014